The documented ability of the AhR antagonist CH223191 to inhibit TCDD- but not IR-dependent gene expression in rat hepatoma cells suggests that these two ligands differentially interact with the AhR LBD [22]. Here, AHR is linked to hepatocellular carcinoma.